Evidence map›Paper›PMID 37337301›Full record

ArticleMilitary Medical Research2023

Single-cell transcriptome profiling of sepsis identifies HLA-DR

Ren-Qi Yao, Peng-Yue Zhao, Zhi-Xuan Li, Yu-Yang Liu, Li-Yu Zheng, Yu Duan, Lu Wang, Rong-Li Yang, Hong-Jun Kang, Ji-Wei Hao and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Military Medical Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The transcriptome of CD14The European respiratory journal · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Ren-Qi Yao *Translational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Peng-Yue Zhao *Translational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Zhi-Xuan Li *Translational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Yu-Yang Liu *Department of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Li-Yu ZhengTranslational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Yu DuanTranslational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Lu WangDepartment of Critical Care Medicine, the First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Rong-Li YangIntensive Care Unit, Dalian Municipal Central Hospital Affiliated Dalian University of Technology, Dalian, 116033, Liaoning, China.
Hong-Jun KangDepartment of Critical Care Medicine, the First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Ji-Wei HaoTranslational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Jing-Yan LiDepartment of Emergency, the Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Ning DongTranslational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Yao WuTranslational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Xiao-Hui DuDepartment of General Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Feng ZhuDepartment of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
Chao RenDepartment of Pulmonary and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100020, China.
Guo-Sheng WuDepartment of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China. drwuguosheng@sina.cn.
Zhao-Fan XiaDepartment of Burn Surgery, the First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China. xiazhaofan_smmu@163.com.
Yong-Ming YaoTranslational Medicine Research Center, Medical Innovation Research Division and the Fourth Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. c_ff@sina.com.ORCID 0000-0002-3564-4012
Chinese PLA General Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNCapital Medical University · CNChinese Academy of Sciences · CNDalian University of Technology · CNHebei Medical University · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSustained yet intractable immunosuppression is commonly observed in septic patients, resulting in aggravated clinical outcomes. However, due to the substantial heterogeneity within septic patients, precise indicators in deciphering clinical trajectories and immunological alterations for septic patients remain largely lacking.

methodsWe adopted cross-species, single-cell RNA sequencing (scRNA-seq) analysis based on two published datasets containing circulating immune cell profile of septic patients as well as immune cell atlas of murine model of sepsis. Flow cytometry, laser scanning confocal microscopy (LSCM) imaging and Western blotting were applied to identify the presence of S100A9

resultsScRNA-seq analysis of human sepsis revealed substantial heterogeneity in monocyte compartments following the onset of sepsis, for which distinct monocyte subsets were enriched in disparate subclusters of septic patients. We identified a unique monocyte subset characterized by high expression of S100A family genes and low expression of human leukocyte antigen DR (HLA-DR), which were prominently enriched in septic patients and might exert immunosuppressive function. By combining single-cell transcriptomics of murine model of sepsis with in vivo experiments, we uncovered a similar subtype of monocyte significantly associated with late sepsis and immunocompromised status of septic mice, corresponding to HLA-DR

conclusionsThis study identifies HLA-DR

Indexed as

MonocytesSepsisAnimalsDisease Models, AnimalHLA-DR AntigensHumansMiceHLA-DR AntigensHuman leukocyte antigen DR (HLA-DR)ImmunosuppressionMonocytesMyeloid-derived suppressor cells (MDSCs)PaquinimodS100ASepsisSingle-cell analysis

Identifiers

PMID37337301
PMCPMC10278311
OpenAlexW4381166387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.